Clinical Trials Directory

Trials / Unknown

UnknownNCT01932450

Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control

A Randomized, Open-label Study Investigating the Effect of Bilateral Renal Artery Sympathetic Denervation by Catheter-based Radiofrequency Ablation on Blood Pressure and Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Mei changlin · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

A randomized, open-label single-center study investigates the efficacy and safety of bilateral renal artery sympathetic denervation by catheter-based radiofrequency ablation on blood pressure and disease progression control in autosomal dominant polycystic kidney disease(ADPKD). The total number of study subjects will be 100. All of them have diagnosed with ADPKD and hypertension. Patients will be randomized 1:1 (50 with radiofrequency ablation(RFA), 50 only with drugs). Change in average office-based measurements of systolic blood pressure(SBP), average 24-hour systolic blood pressure by ambulatory blood pressure monitoring (ABPM) , incidence of office systolic blood pressure reductions of ≥10, ≥15 and ≥20 mm Hg , office diastolic blood pressure (DBP), number and dosage of blood pressure tablets, total kidney volume (TKV), total cyst volume (TCV), pain related to cystic kidneys and renal function, will be assessed at 12 months of follow-up. The safety variables will be assessed at every visit of follow-up.

Conditions

Interventions

TypeNameDescription
PROCEDURErenal sympathetic denervationOne-time standard Catheter-based renal sympathetic denervation will be performed in both renal arteries by radiofrequency ablation.
DRUGantihypertensive drugsantihypertensive drugs have been used from baseline in patients, and will be modified by patient's blood pressure.

Timeline

Start date
2013-08-01
Primary completion
2014-12-01
Completion
2015-07-01
First posted
2013-08-30
Last updated
2014-09-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01932450. Inclusion in this directory is not an endorsement.